Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Ovarian Sex Cord-Stromal Tumors in Patients With Probable or Confirmed Germline DICER1 Mutations.

Oost EE, Charles A, Choong CS, Leung YC, Salfinger S, Sonnendecker H, Tan J, Townshend S, Witkowski L, Foulkes WD, Stewart CJ.

Int J Gynecol Pathol. 2015 May;34(3):266-74. doi: 10.1097/PGP.0000000000000150.

PMID:
25844550
2.

Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease.

Nicolai N, Necchi A, Raggi D, Biasoni D, Catanzaro M, Piva L, Stagni S, Maffezzini M, Torelli T, Faré E, Giannatempo P, Pizzocaro G, Colecchia M, Salvioni R.

Urology. 2015 Feb;85(2):402-6. doi: 10.1016/j.urology.2014.10.021.

PMID:
25623702
3.

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors.

Ray-Coquard I, Brown J, Harter P, Provencher DM, Fong PC, Maenpaa J, Ledermann JA, Emons G, Rigaud DB, Glasspool RM, Mezzanzanica D, Colombo N.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S42-7. doi: 10.1097/IGC.0000000000000249.

PMID:
25341579
4.

Clinical outcomes of local and metastatic testicular sex cord-stromal tumors.

Silberstein JL, Bazzi WM, Vertosick E, Carver BS, Bosl GJ, Feldman DR, Bajorin DF, Motzer RJ, Al-Ahmadie H, Reuter VE, Sheinfeld J.

J Urol. 2014 Aug;192(2):415-9. doi: 10.1016/j.juro.2014.01.104. Epub 2014 Feb 8.

PMID:
24518791
5.

Clinicopathological spectrum of ovarian sex cord-stromal tumors; 20 years' retrospective study in a developing country.

Haroon S, Zia A, Idrees R, Memon A, Fatima S, Kayani N.

J Ovarian Res. 2013 Dec 5;6(1):87. doi: 10.1186/1757-2215-6-87.

6.

Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network.

Maillet D, Goulvent T, Rimokh R, Vacher-Lavenu MC, Pautier P, Alexandre J, Pujade-Laurraine E, Devouassoux-Shisheboran M, Treilleux I, Ray-Coquard I, Savina A.

Gynecol Oncol. 2014 Jan;132(1):181-7. doi: 10.1016/j.ygyno.2013.10.013. Epub 2013 Oct 22.

PMID:
24157616
7.

An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.

Stewart CJ, Alexiadis M, Crook ML, Fuller PJ.

Hum Pathol. 2013 Dec;44(12):2774-81. doi: 10.1016/j.humpath.2013.07.028. Epub 2013 Oct 14.

PMID:
24134930
8.

Testicular sex cord stromal tumors: analysis of patients from the MAKEI study.

Hofmann M, Schlegel PG, Hippert F, Schmidt P, von-Schweinitz D, Leuschner I, Göbel U, Calaminus G, Schneider DT; MAKEI study group.

Pediatr Blood Cancer. 2013 Oct;60(10):1651-5. doi: 10.1002/pbc.24607. Epub 2013 Jun 3.

PMID:
23733594
9.

[Current treatment strategy of sex cord--stromal tumors of the ovary by molecular targeted therapy].

Watanabe Y, Ekawa Y, Hoshiai H.

Nihon Rinsho. 2012 Jun;70 Suppl 4:656-8. Japanese. No abstract available.

PMID:
23156327
10.

GATA-4 and FOG-2 expression in pediatric ovarian sex cord-stromal tumors replicates embryonal gonadal phenotype: results from the TREP project.

Virgone C, Cecchetto G, Ferrari A, Bisogno G, Donofrio V, Boldrini R, Collini P, Dall'Igna P, Alaggio R.

PLoS One. 2012;7(9):e45914. doi: 10.1371/journal.pone.0045914. Epub 2012 Sep 24.

11.

Sex cord stromal tumors-unusual presentations.

Mehta S, Rajaram S, Goel N, Radhika AG, Agarwal N.

J Obstet Gynaecol India. 2011 Oct;61(5):543-5. Epub 2011 Oct 29.

12.

Management of ovarian and testicular sex cord-stromal tumors in children and adolescents.

Schultz KA, Schneider DT, Pashankar F, Ross J, Frazier L.

J Pediatr Hematol Oncol. 2012 May;34 Suppl 2:S55-63. doi: 10.1097/MPH.0b013e31824e3867. Review.

PMID:
22525408
13.

Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary.

Gershenson DM.

Gynecol Oncol. 2012 Jun;125(3):515-7. doi: 10.1016/j.ygyno.2012.03.019. Epub 2012 Mar 14. No abstract available.

PMID:
22426486
14.

Immunohistochemical characterization of nonhuman primate ovarian sex cord-stromal tumors.

Durkes A, Garner M, Juan-Sallés C, Ramos-Vara J.

Vet Pathol. 2012 Sep;49(5):834-8. doi: 10.1177/0300985811432345. Epub 2012 Jan 24.

15.

Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.

Schultz KA, Pacheco MC, Yang J, Williams GM, Messinger Y, Hill DA, Dehner LP, Priest JR.

Gynecol Oncol. 2011 Aug;122(2):246-50. doi: 10.1016/j.ygyno.2011.03.024. Epub 2011 Apr 17.

16.

Sex cord stromal tumors of the ovary in children: a clinicopathological report from the Italian TREP project.

Cecchetto G, Ferrari A, Bernini G, Alaggio R, Collini P, Virgone C, Terenziani M, Dall'igna P, Cozza R, Conte M, Bisogno G.

Pediatr Blood Cancer. 2011 Jul 1;56(7):1062-7. doi: 10.1002/pbc.22918. Epub 2010 Dec 15.

PMID:
21488154
17.

Patterns of spread and recurrence of sex cord-stromal tumors of the ovary.

Thrall MM, Paley P, Pizer E, Garcia R, Goff BA.

Gynecol Oncol. 2011 Aug;122(2):242-5. doi: 10.1016/j.ygyno.2011.03.020. Epub 2011 Apr 9.

18.

FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.

Al-Agha OM, Huwait HF, Chow C, Yang W, Senz J, Kalloger SE, Huntsman DG, Young RH, Gilks CB.

Am J Surg Pathol. 2011 Apr;35(4):484-94. doi: 10.1097/PAS.0b013e31820a406c.

PMID:
21378549
19.

Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors.

Hes O, Vaněček T, Petersson F, Grossmann P, Hora M, Perez Montiel DM, Steiner P, Dvořák M, Michal M.

Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):347-51. doi: 10.1097/PAI.0b013e3182039ef2.

PMID:
21293260
20.

Steroidogenic acute regulatory protein is a useful marker for Leydig cells and sex-cord stromal tumors.

Dong L, Wang H, Su Z, Niu S, Wang R, Wu L, Chen G.

Appl Immunohistochem Mol Morphol. 2011 May;19(3):226-32. doi: 10.1097/PAI.0b013e3181ffc4d2.

PMID:
21217523
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk